Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Glucose Homeostasis in Newborns: An Endocrinology Perspective
Emir Tas1, Luigi Garibaldi2, Radhika Muzumdar2
1Division of Endocrinology and Diabetes, Department of Pediatrics, Arkansas Children's Hospital, Little Rock, AR.
Insights
Neonatal glucose homeostasis relies on postnatal adaptations and feeding. Maintaining normal blood glucose levels is crucial for preventing neurodevelopmental issues in newborns.
Area of Science:
- Neonatal physiology and endocrinology
- Pediatric metabolic disorders
Background:
- Plasma glucose regulation in newborns is complex, influenced by physiological changes and enteral feeding.
- Defining normal neonatal glucose ranges lacks definitive clinical correlation, leading to ongoing debate.
- Consensus exists on the importance of maintaining glucose within age-appropriate ranges to prevent adverse neurodevelopmental outcomes.
Purpose of the Study:
- To review the physiological mechanisms governing glucose homeostasis in newborns.
- To discuss the diagnostic and management approaches for neonates with disordered glucose metabolism.
- To emphasize the endocrine underpinnings of abnormal glucose regulation in the neonatal period.
Main Methods:
- Review of physiological processes involved in maintaining neonatal plasma glucose.
- Discussion of clinical approaches to managing abnormal glucose levels in newborns.
- Emphasis on the endocrine factors contributing to glucose dysregulation.
Main Results:
- Physiological adaptations and enteral feeding are key to maintaining neonatal glucose levels.
- Management strategies for neonatal hyperglycemia and hypoglycemia are etiology-dependent.
- Interventions range from nutritional support to medications, hormone therapy, and surgery.
Conclusions:
- Maintaining appropriate plasma glucose levels in neonates is vital for preventing short- and long-term neurodevelopmental consequences.
- Understanding the endocrine basis of glucose homeostasis is critical for effective management of neonatal glucose abnormalities.
- A tailored approach considering the underlying cause is essential for managing disordered glucose homeostasis in newborns.
Abstract:
Physiologic adaptations in the postnatal period, along with gradual establishment of enteral feeding, help maintain plasma glucose concentrations in the neonatal period. The definition of normal plasma glucose in the neonatal period has been a subject of debate because of a lack of evidence linking a set plasma or blood glucose concentration to clinical symptoms or predictors of short- and long-term outcomes. However, there is consensus that maintaining plasma glucose in the normal range for age is important to prevent immediate and long-term neurodevelopmental consequences of hypoglycemia or hyperglycemia. The specific management strategy for abnormal glucose levels in neonates depends on the underlying etiology, and interventions could include nutritional changes, medications, hormone therapy, or even surgery. Here, we will review the physiological processes that help maintain plasma glucose in newborns and discuss the approach to a newborn with disordered glucose homeostasis, with an emphasis on the endocrine basis of abnormal glucose homeostasis.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

